{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:31:21Z","timestamp":1794385881413,"version":"4.9.0"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T00:00:00Z","timestamp":1263254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>\n                    <jats:bold>Summary.\u2002<\/jats:bold>\n                    All UK patients with bleeding disorders treated with any UK\u2010sourced pooled factor concentrates between 1980 and 2001 have been informed that they may be at an increased risk of infection with variant Creutzfeldt\u2013Jakob disease (vCJD). We describe a study to detect disease\u2010associated, protease\u2010resistant prion protein (PrP\n                    <jats:sup>res<\/jats:sup>\n                    ) in 17 neurologically aysmptomatic patients with haemophilia considered to be at increased risk of vCJD. Materials from 11 autopsy and seven biopsy cases were analysed for PrP\n                    <jats:sup>res<\/jats:sup>\n                    . The tissues available from each case were variable, ranging from a single biopsy sample to a wide range of autopsy tissues. A single specimen from the spleen of one autopsy case gave a strong positive result on repeated testing for PrP\n                    <jats:sup>res<\/jats:sup>\n                    by Western blot analysis. This tissue came from a 73\u2010year\u2010old male patient with no history of neurological disease, who was heterozygous (methionine\/valine) at codon 129 in the prion protein gene. He had received over 9000\u2003units of factor VIII concentrate prepared from plasma pools known to include donations from a vCJD\u2010infected donor, and some 400\u2003000\u2003units not known to include donations from vCJD\u2010infected donors. He had also received 14\u2003units of red blood cells and had undergone several surgical and invasive endoscopic procedures. Estimates of the relative risks of exposure through diet, surgery, endoscopy, blood transfusion and receipt of UK\u2010sourced plasma products suggest that by far the most likely route of infection in this patient was receipt of UK plasma products.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2516.2009.02181.x","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T01:15:33Z","timestamp":1263258933000},"page":"296-304","source":"Crossref","is-referenced-by-count":217,"title":["Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia"],"prefix":"10.1111","volume":"16","author":[{"given":"A.","family":"PEDEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"McCARDLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"HEAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"LOVE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J. T.","family":"WARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"COUSENS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"KEELING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"MILLAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G. H.","family":"HILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"IRONSIDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,25]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/39057"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15137"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20708"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05411-3"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63105-7"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69835-8"},{"key":"e_1_2_8_11_2","first-page":"2","article-title":"Fourth case of transfusion\u2010associated variant\u2010CJD infection","volume":"1","author":"Health Protection Agency","year":"2007","journal-title":"Health Protect Report"},{"key":"e_1_2_8_12_2","unstructured":"Joint UKBTS\/NIBSC Professional Advisory Committee Position Statement.2007.http:\/\/www.transfusionguidelines.org.uk\/index.aspx?Publication=DL&Section=12&pageid=794. Accessed October 16 2009."},{"key":"e_1_2_8_13_2","volume-title":"Risk of Infection From Variant CJD in Blood","author":"Det Norske Veritas","year":"2004"},{"key":"e_1_2_8_14_2","volume-title":"Variant CJD and Plasma Products","author":"Health Protection Agency","year":"2009"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1580"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2004.0017"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1442"},{"key":"e_1_2_8_18_2","volume-title":"Position Statement: Prevalence of Subclinical Variant Creutzfeldt\u2010Jakob Disease Infections","author":"Spongiform Encephalopathy Advisory Committee","year":"2008"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20127"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05403-4"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030351"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2003.00544.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64705-0"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/jcpa.2002.0592"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00833.x"},{"key":"e_1_2_8_26_2","volume-title":"VCJD Risk Assessment Calculations for a Patient With Multiple Routes of Exposure","author":"Bennett PG","year":"2009"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152520"},{"key":"e_1_2_8_28_2","volume-title":"National Human Post\u2010Mortem Tissue Archive to Study the Prevalence of Abnormal Prion Protein","author":"Health Protection Agency","year":"2007"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1057\/ori.2006.15","article-title":"The implications for blood donors if a recipient develops variant Creutzfeldt\u2010Jakob disease","volume":"19","author":"Bennett PG","year":"2006","journal-title":"OR Insight"},{"key":"e_1_2_8_30_2","volume-title":"Assessing the Risk of VCJD Transmission via Surgery: An Interim Review","author":"Department of Health","year":"2005"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2009.02181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2009.02181.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:36:53Z","timestamp":1698669413000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2009.02181.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,25]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-2516.2009.02181.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02181.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2263956.1880054","asserted-by":"object"}]},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,25]]}}}